Combat AMR with rapid diagnostics

Roche and 12 other companies are developing a new roadmap that should contribute to a sustainable solution to the resistance problem. Rapid and reliable diagnostics of microorganisms play an important role: the correct diagnosis prevents the unnecessary use of antibiotics. Studies show that now about 50% of the antibiotics are used unnecessarily. For example, antibiotics are prescribed twice as often in the US as in some European countries. With the right point-of-care tests doctors can, without the delaying intervention of central laboratories, make a quick and accurate diagnosis. Several point-of-care tests have come on the market in recent years. Use is made of the fast PCR technology that produces results within 15-20 minutes. The combination of PCR and point-of-care diagnostics can also be used to identify specific flu viruses. This helps doctors to decide to prescribe the appropriate anti-viral drugs. Hospital bacteria can also be identified with the tests. However important the new generations of tests are, they are only part of the solution.

To other news


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!